Pain Reduction, Feasibility, and Quality of Life of 2% Lidocaine Spray versus 2% Lidocaine Oral Viscous for Head and Neck Cancer Patients with Chemoradiation-Induced Mucositis: A Randomized phase 2 study

Authors
Category Primary study
Registry of TrialsThai Clinical Trials Registry
Year 2024
This article has no abstract
Epistemonikos ID: 53dc4c0885a60de3c440320c74fcd171d498b1cd
First added on: Apr 11, 2025